Physician

Andres Nisimblat, M.D.

According to 2025 Medicare claims, Andres Nisimblat, M.D. (NPI: 1467469205) practices family practice in the Corpus Christi, TX market, with the plurality of this provider's patient population coming from Nueces, TX. This provider's primary affiliated billing organization is CORPUS CHRISTI MEDICAL ASSOCIATES, P.A. (NPI: 1164713848; TIN: 451877521) and primary practice location at 78414-3478. Nisimblat is affiliated with the Aledade 158 TX MSSP Enhanced (ACO ID: A5361), participating under the MSSP model.

Nisimblat's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 759 traditional Medicare patients, billed 31,071 HCPCS/CPT codes, and received $376,012 in Medicare payments. The top billing code was 84443 (Blood test, thyroid stimulating hormone (tsh)). Part D data shows 8,637 prescription claims across 523 beneficiaries totaling $1,034,633 in drug costs, led by Ozempic (Semaglutide). DME data shows 321 claims. Open Payments data shows 127 records totaling $1,962. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $267,346 to $376,012. Similarly, Part D prescription costs have risen steadily, from $398,363 to $1,034,633. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $12,299 and ending at $18,972.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	551	24,572	$267,346
2016	568	31,216	$259,101
2017	498	31,078	$247,197
2018	497	23,923	$219,516
2019	494	23,077	$228,640
2020	519	22,419	$246,028
2021	839	32,169	$335,445
2022	766	25,412	$333,355
2023	814	24,938	$361,299
2024	759	31,071	$376,012

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	330	6,199	$398,363
2016	355	6,304	$424,997
2017	374	6,831	$453,795
2018	397	7,013	$540,867
2019	428	7,476	$603,543
2020	420	7,389	$590,228
2021	455	7,376	$650,308
2022	450	7,343	$736,886
2023	462	7,709	$932,849
2024	523	8,637	$1,034,633

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	98	351	$6,785
2016	116	420	$7,084
2017	58	342	$8,070
2018	84	292	$6,612
2019	54	311	$17,022
2020	46	328	$20,145
2021	38	211	$15,000
2022	78	324	$15,441
2023	122	425	$21,315
2024	87	321	$11,220

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
84443	Blood test, thyroid stimulating hormone (tsh)	561	698	$16
80061	Blood test, lipids (cholesterol and triglycerides)	585	1,042	$13
80053	Blood test, comprehensive group of blood chemicals	654	1,307	$10
36415	Insertion of needle into vein for collection of blood sample	622	1,402	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	635	980	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	252	8,150	$252,541
Eliquis	Apixaban	126	6,385	$120,344
Jardiance	Empagliflozin	94	4,740	$82,108
Mounjaro	Tirzepatide	49	1,664	$60,209
Juluca	Dolutegravir/Rilpivirine	12	360	$48,051

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	11	68	$2,238
A7031	Face mask interface, replacement for full face mask, each	N	N/R	27	$1,968
A7030	Full face mask used with positive airway pressure device, each	N	N/R	21	$1,913
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	14	27	$1,305
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	13	$1,059

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	127	$1,962	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andres Nisimblat, M.D.?

Tedicare shows public-source Medicare data for Andres Nisimblat, M.D. (NPI 1467469205), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andres Nisimblat, M.D. have ACO affiliation data?

Andres Nisimblat, M.D. is shown with ACO affiliation data for Aledade 158 TX MSSP Enhanced (MSSP, ACO ID A5361).

What billing organization is linked to Andres Nisimblat, M.D.?

Andres Nisimblat, M.D. is linked to CORPUS CHRISTI MEDICAL ASSOCIATES, P.A. (billing NPI 1164713848) in the available physician profile data.

Does Andres Nisimblat, M.D. have Open Payments data?

Andres Nisimblat, M.D. has 127 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.